
A newly established coordinated validation framework aims to ensure diverse cohort representation and harmonize assay standards in the burgeoning field of epigenetic biomarkers. This initiative prioritizes cross-population benchmarking of methylation clocks and the scaling of epigenetic editing, fostering partnerships with indigenous and underrepresented groups to enhance equitable health outcomes. While the advancements provide optimism for high-sensitivity diagnostics in cancer and chronic diseases, caution is urged regarding population bias and technical complexities.

Title not available for this citation.
“Therefore, epigenomic information may contain robust cancer biomarkers, suggesting that the development of epigenetic diagnostics will enable accurate disease stratification, prediction of treatment response and prognosis.”

Title not available for this citation.
“However, in managing advanced colorectal cancer, as in other cancers, gene mutations and the expression of their products, but not epigenomic information, have been used to guide treatment or predict prognosis.”

Title not available for this citation.
“This paper examines the integration of a values-based framework to ensure the culturally safe conduct of DNAm research within the Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS) cohort.”